SUMMARY Plasma lipid concentration and post-heparin lipolytic activity in twenty-two epileptic children treated either with phenobarbitone or sodium valproate were evaluated. An increase of phospholipid was observed in whole blood as well as in the low-density and high-density lipoproteins in patients undergoing phenobarbitone treatment. No change was found in subjects treated with sodium valproate. The enzyme activities were slightly, but not statistically significantly, increased in the two groups compared with the control subJects.
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Chronic administration of antiepileptic drugs is often accompanied by untoward side effects including metabolic and endocrine abnormalities.' 2 Moreover some anticonvulsant drugs metabolised by the liver are powerful enzyme-inducing agents, and stimulate the enzymatic activities concerned with steroid hydroxylation, the bilirubin pathway, and lipid synthesis and metabolism.3
The purpose of this study was to evaluate plasma lipid concentration in epileptic children treated with two of the most common anticonvulsants: phenobarbitone and sodium valproate. We also measured the post-heparin plasma activity of two enzymes, the lipoprotein-lipase and hepatic triglyceride-lipase, which are directly related to lipid metabolism.
Patients and methods
Twenty-two children (13 males and nine females) were included in this study. The age range was from 3 to 9 years (mean 7 years). Eighteen patients had grand-mal convulsions, one had petit mal absence, and the remaining three had infantile spasms. Seventeen patients were treated with phenobarbitone 5 mg/kg/day over a period of 6 months to 8 years (mean 4 years). The serum concentration of this drug varied from 10 to 25 jug/ml. Five patients were treated with 20 mg/kg/day of sodium valproate over a period of 16 months to 3 years (mean 2 years). Blood concentrations of this drug ranged from and sexes were used as controls. Serum transaminases were within the normal limits in all the patients, and prothrombin activity exceeded 70%.
Blood samples for lipid analysis were taken while the subjects were on ordinary diet in the morning and after fasting for at least 12 hours. Triglycerides and cholesterol were determined in the whole serum on a Technicon Autoanalyzer II as described by Lowry et al4 and Bloor.5 Triglycerides, cholesterol and phospholipids were also determined by the same methods in the very low, low and high-density lipoprotein fractions separated by sequential ultracentrifugation in a Spinco-L ultracentrifuge. The post-heparin lipolytic activity after intravenous injection of heparin 60 u/kg body weight was determined by immunochemical methods as described by Greten et al. 6 The results are expressed as mean + SD, the significance of the differencebetween patients and controls was calculated by Student's t test.
Results
The 
